These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19920387)

  • 1. [Safety evaluation of paclitaxel injection NK in adjuvant therapy for breast cancer].
    Takahara S; Yamamoto H; Tokushima Y; Shiba E
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1851-6. PubMed ID: 19920387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the pharmacokinetics and safety of a paclitaxel injection NK and Taxol injection in breast cancer patients].
    Sagara Y; Rai Y; Sagara Y; Matsuyama Y; Baba S; Tamada S; Sagara Y; Ando M
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):247-50. PubMed ID: 19223739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of a safety evaluation between paclitaxel injection NK and Taxol®].
    Yamamoto D; Tsubota Y; Sueoka N; Yokoi T; Inoue K; Ohira M; Muranaka T
    Gan To Kagaku Ryoho; 2013 Jul; 40(7):959-61. PubMed ID: 23863746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Taxol (paclitaxel) as second-line therapy in breast and ovarian cancer].
    Borovik R; Steiner M; Atad J; Sneiderman B; Rosenberg T; Palti S
    Harefuah; 1998 Apr; 134(8):605-8, 671. PubMed ID: 10911422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
    Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T
    Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case successfully treated by desensitization for paclitaxel-associated hypersensitivity reactions].
    Yamatoya Y; Wada Y; Sato S; Morikawa T; Sakata N; Nakata J; Seki K; Wada N; Kamiyama K; Tominaga T
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):271-4. PubMed ID: 17301542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy with weekly paclitaxel in breast cancer patients may increase release of cancer cells into circulation by decreasing interstitial fluid pressure.
    Altundag O; Altundag K; Gundeslioglu O; Silay YS; Ersoy Y
    Med Hypotheses; 2006; 66(4):857-8. PubMed ID: 16039067
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiac dysfunction in cancer patients receiving paclitaxel.
    Valdés Olmos RA; ten Bokkel Huinink WW; Hoefnagel CA
    Eur J Nucl Med; 1998 Apr; 25(4):446-7. PubMed ID: 9643974
    [No Abstract]   [Full Text] [Related]  

  • 9. HER2 and response to paclitaxel in node-positive breast cancer.
    Mehta R
    N Engl J Med; 2008 Jan; 358(2):197-8; author reply 198. PubMed ID: 18193531
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of safety in clinical use of generic paclitaxel [NK] for injection.
    Tsukiyama I; Hotta K; Takeuchi M; Onishi M; Toyama Y; Saito H; Sai Y; Miyamoto K; Hasegawa T
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):613-7. PubMed ID: 22504687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy-related acute myeloid leukemia with 11q23 abnormality due to paclitaxel coexisting with bone marrow metastasis of breast cancer].
    Saito M; Mori A; Irie T; Tanaka M; Morioka M
    Rinsho Ketsueki; 2009 Mar; 50(3):192-6. PubMed ID: 19352087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed seizure associated with paclitaxel-Cremophor el in a patient with early-stage breast cancer.
    O'Connor TL; Kossoff E
    Pharmacotherapy; 2009 Aug; 29(8):993-6. PubMed ID: 19637953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invited commentary.
    Campbell KL; McNeely ML
    Phys Ther; 2010 Nov; 90(11):1657-9; author reply 1659. PubMed ID: 21041184
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reinduction of paclitaxel therapy after a successfully treated hypersensitivity reaction].
    Lehoczky O; Bagaméri A; Pulay T
    Orv Hetil; 2002 Sep; 143(38):2189-91. PubMed ID: 12395475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-induced cardiotoxicity. An ultrastructural study.
    Shek TW; Luk IS; Ma L; Cheung KL
    Arch Pathol Lab Med; 1996 Jan; 120(1):89-91. PubMed ID: 8554453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited cutaneous systemic sclerosis induced by paclitaxel in a patient with breast cancer.
    Kawakami T; Tsutsumi Y; Soma Y
    Arch Dermatol; 2009 Jan; 145(1):97-8. PubMed ID: 19153362
    [No Abstract]   [Full Text] [Related]  

  • 17. [Paclitaxel for treatment of colorectal cancer].
    Ushigome T; Kawahara S; Hirai K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():338-40. PubMed ID: 14574907
    [No Abstract]   [Full Text] [Related]  

  • 18. Peripheral neuropathy in a woman with breast cancer.
    Cianfrocca M; Flatters SJ; Bennett GJ; McNicol E; Relias V; Carr D; Gillis TA
    J Pain; 2006 Jan; 7(1):2-10. PubMed ID: 16414547
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe necrosis due to paclitaxel extravasation.
    Herrington JD; Figueroa JA
    Pharmacotherapy; 1997; 17(1):163-5. PubMed ID: 9017777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metronomic schedule of paclitaxel is effective in hormone receptor-positive and hormone receptor-negative breast cancer.
    Mehta RS; Jackson D; Schubbert T
    J Clin Oncol; 2009 Jun; 27(18):3067-8; author reply 3068-9. PubMed ID: 19451417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.